BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6406593)

  • 1. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and LYT-2,3. I. Increased susceptibility to blocking after papain treatment of target cells.
    Gromkowski SH; Heagy W; Sanchez-Madrid F; Springer TA; Martz E
    J Immunol; 1983 Jun; 130(6):2546-51. PubMed ID: 6406593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    Gromkowski SH; Heagy W; Martz E
    J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
    J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
    Bonavida B; Katz J
    J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte function-associated antigens: regulation of lymphocyte adhesions in vitro and immunity in vivo.
    Martz E; Gromkowski SH
    Adv Exp Med Biol; 1985; 184():291-310. PubMed ID: 3898752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.
    Leo O; Foo M; Henkart PA; Perez P; Shinohara N; Segal DM; Bluestone JA
    J Immunol; 1987 Dec; 139(11):3556-63. PubMed ID: 3316387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of anti-CD8-resistant cytolytic T lymphocytes induced by multivalent cross-linking of CD8 on precursor cells.
    McCarthy SA; Kaldjian E; Singer A
    J Immunol; 1989 Oct; 143(7):2112-9. PubMed ID: 2528588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional distinctions between the LFA-1, LFA-2, and LFA-3 membrane proteins on human CTL are revealed with trypsin-pretreated target cells.
    Gromkowski SH; Krensky AM; Martz E; Burakoff SJ
    J Immunol; 1985 Jan; 134(1):244-9. PubMed ID: 3871102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse alloantibodies capable of blocking cytotoxic T cell function. V. The majority of I region-specific CTL are Lyt-2+ but are relatively resistant to anti-Lyt-2 blocking.
    Shinohara N; Kojima M
    J Immunol; 1984 Feb; 132(2):578-83. PubMed ID: 6197465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T3 monoclonal antibody activation of nonspecific cytolysis: a mechanism of CTL inhibition.
    Mentzer SJ; Barbosa JA; Burakoff SJ
    J Immunol; 1985 Jul; 135(1):34-8. PubMed ID: 2582036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of cytotoxic T lymphocyte (CTL) clones to inhibition by anti-T3 and anti-T4 (but not anti-LFA-1) monoclonal antibodies varies with the "avidity" of CTL-target interaction.
    Shaw S; Goldstein G; Springer TA; Biddison WE
    J Immunol; 1985 May; 134(5):3019-26. PubMed ID: 2580011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysis of hybridoma cells bearing anti-clonotypic surface immunoglobulin by clonotype-expressing alloreactive cytotoxic T cells.
    Hua C; Buferne M; Schmitt-Verhulst AM
    Eur J Immunol; 1985 Oct; 15(10):1029-33. PubMed ID: 3902483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal cytotoxic T lymphocyte hybridomas capable of specific killing activity, antigenic responsiveness, and inducible interleukin secretion.
    Kaufmann Y; Berke G
    J Immunol; 1983 Jul; 131(1):50-6. PubMed ID: 6190926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LFA-1, LFA-2, and LFA-3 antigens are involved in CTL-target conjugation.
    Krensky AM; Robbins E; Springer TA; Burakoff SJ
    J Immunol; 1984 May; 132(5):2180-2. PubMed ID: 6201533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytolytic T lymphocyte clones that proliferate autonomously to specific alloantigenic stimulation. II. Relationship of the Lyt-2 molecular complex to cytolytic activity, proliferation, and lymphokine secretion.
    Glasebrook AL; Kelso A; MacDonald HR
    J Immunol; 1983 Apr; 130(4):1545-51. PubMed ID: 6187814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel lymphocyte function-associated antigen (LFA-1): cellular distribution, quantitative expression, and structure.
    Kürzinger K; Reynolds T; Germain RN; Davignon D; Martz E; Springer TA
    J Immunol; 1981 Aug; 127(2):596-602. PubMed ID: 6788846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal anti-Lyt-2 antibodies block the activation of cytolytic T lymphocyte precursors.
    Glasebrook AL; MacDonald HR
    J Immunol; 1983 Apr; 130(4):1552-5. PubMed ID: 6220055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target cell recognition structures in LDCC and ODCC.
    Gorman KC; Kane KP; Clark WR
    J Immunol; 1987 Feb; 138(4):1014-9. PubMed ID: 3100625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.